Boucher Kelley 4
4 · Apellis Pharmaceuticals, Inc. · Filed Jun 11, 2025
Insider Transaction Report
Form 4
Boucher Kelley
Chief People Officer
Transactions
- Award
Common Stock
2025-06-09+45,095→ 67,182 total - Award
Stock Option (Right to Buy)
2025-06-09$19.39/sh+67,396$1,306,808→ 67,396 totalExercise: $19.39Exp: 2035-06-09→ Common Stock (67,396 underlying)
Footnotes (2)
- [F1]This represents an award of Restricted Stock Units granted June 9, 2025, that vests annually from grant date over a four-year period subject to continued service.
- [F2]This represents a stock option award granted June 9, 2025 that vests over a four-year period. 25% vests one year from grant date and the remaining 75% vests monthly thereafter subject to continued service.